MFS Emerging Markets Debt R2 (MEDEX)

Fund Assets	7.52B
Expense Ratio	1.32%
Min. Investment	$0.00
Turnover	69.00%
Dividend (ttm)	0.64
Dividend Yield	5.02%
Dividend Growth	-3.92%
Payout Frequency	Monthly
Ex-Dividend Date	Jul 31, 2026

Previous Close	12.67
YTD Return	2.17%
1-Year Return	7.24%
5-Year Return	8.12%
52-Week Low	12.40
52-Week High	12.99
Beta (5Y)	0.37
Holdings	552
Inception Date	Dec 1, 2008

About MEDEX

The MFS Emerging Markets Debt Fund Class R2 is a mutual fund that seeks to deliver a total return with a primary emphasis on high current income, while also considering long-term capital appreciation. This fund invests predominantly in a diversified portfolio of debt securities issued by sovereign and corporate entities in emerging market countries, with a focus on both U.S. dollar and local currency denominated bonds. Its investment process is notably research-driven, emphasizing active country and security selection alongside disciplined risk management and downside protection. The fund further manages volatility through broad diversification and maintaining liquid holdings. The fund is benchmarked against the JPMorgan Emerging Markets Bond Index Global, reflecting its aim to capture opportunities and manage risks across a wide array of developing markets. As of May 2025, the portfolio held hundreds of issues across nearly 180 issuers, demonstrating significant breadth and diversification. The management team brings substantial continuity and experience, having steered the fund through multiple market cycles since inception. The fund plays a key role in providing access to emerging market fixed income opportunities, contributing to global portfolio diversification and offering exposure to dynamic economies outside the developed markets.

• Fund Family: MFS
• Category: Emerging Markets Bond
• Performance Rating: Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: MEDEX
• Share Class: R2
• Index: JP Morgan EMBI Global Diversified TR

Performance

MEDEX had a total return of 7.24% in the past year, including dividends. Since the fund's inception, the average annual return has been 5.85%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
FGYMX	Fidelity	Fidelity Advisor New Markets Income Fund - Class C	1.79%
FGWMX	Fidelity	Fidelity Advisor New Markets Income M	1.04%
FGBMX	Fidelity	Fidelity Advisor New Markets Income Z	0.69%
FGZMX	Fidelity	Fidelity Advisor New Markets Income I	0.79%
FNMIX	Fidelity	Fidelity New Markets Income Fund	0.75%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
MEDHX	R6	0.71%
MEDGX	R4	0.82%
MEDIX	I	0.82%
MEDFX	R3	1.07%

Dividend History

Ex-Dividend	Amount	Pay Date
Jul 31, 2026	$0.0571	Aug 3, 2026
Jun 30, 2026	$0.05512	Jul 1, 2026
May 29, 2026	$0.05258	Jun 1, 2026
Apr 30, 2026	$0.05268	May 1, 2026
Mar 31, 2026	$0.0525	Apr 1, 2026
Feb 27, 2026	$0.05254	Mar 2, 2026

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 27, 2026

Data Sources Report a data error